LTBR and neoplasm: Another strategy makes use of the tumor vasculature normalization aspect of the tumor necrosis factor superfamily member 14 (TNFSF14/CD258/LIGHT)/lymphotoxin-β receptor (LTβR) signaling axis coupled with its intrinsic ability to turn a “cold” tumor “hot”.